Survival proteomes: The emerging proteotype of antimicrobial resistance

FEMS Microbiology Reviews

Volumn 40, Issue 3, 2016, Pages 323-342

  Park, Amber J ^a   Krieger, Jonathan R ^b   Khursigara, Cezar M ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Antimicrobial resistance; Experimental design; Mass spectrometry; Pathogenic bacteria; Post translational modifications; Proteomics

Indexed keywords

ANTIBIOTIC AGENT; PROTEIN; PROTEOME; SUBPROTEOME; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; MASS SPECTROMETRY; NONHUMAN; PROTEIN BASED RESISTANCE; PROTEIN MODIFICATION; PROTEOMICS; REVIEW; BACTERIUM; DRUG EFFECTS; GENETICS; TRENDS;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; PROTEOME; PROTEOMICS;

EID: 84975780297     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1093/femsre/fuv051     Document Type: Review

References (75)

1. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 2010;8:260-71.
2. Apweiler R, Bairoch A,Wu CH et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res 2004;32:D115-9.
3. Arthur M, Quintiliani R. Regulation of VanA- and VanB-type glycopeptide resistance in Enterococci. Antimicrob Agents Ch 2001;45:375-81.
4. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. Nat Genet 2000;25:25-9.
5. Beausoleil SA, Villén J, Gerber SA et al. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006;24:1285-92.
6. Bisson GP, Mehaffy C, Broeckling C et al. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampinresistant, rpoB mutant Mycobacterium tuberculosis. J Bacteriol 2012;194:6441-52.
7. Blair JMA,Webber MA, Baylay AJ et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2014;13:42-51.
8. Cain JA, Solis N, Cordwell SJ. Beyond gene expression: the impact of protein post-translational modifications in bacteria. J Proteomics 2014;97:265-86.
9. Chang C-J, Lin J-H, Chang K-C et al. Diagnosis of β-Lactam resistance in Acinetobacter baumannii using shotgun proteomics and LC-Nano-electrospray ionization ion trap mass spectrometry. Anal Chem 2013;85:2802-8.
10. Charretier Y, Köhler T, Cecchini T et al. Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Front Microbiol 2015;6:1-10.
11. Chong PM, Lynch T, McCorrister S et al. Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole. PLoS One 2014;9:e82622.
12. Chopra S, Ramkissoon K, Anderson DC. A systematic quantitative proteomic examination ofmultidrug resistance in Acinetobacter baumannii. J Proteomics 2013;84:17-39.
13. Chua SL, Tan SYY, Rybtke MT et al. Bis-(3″-5″)-cyclic dimeric GMP regulates antimicrobial peptide resistance in Pseudomonas aeruginosa. Antimicrob Agents Ch 2013;57:2066-75.
14. Condell O, Power KA, Händler K et al. Comparative analysis of Salmonella susceptibility and tolerance to the biocide chlorhexidine identifies a complex cellular defense network. Front Microbiol 2014;5:1-26.
15. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008;26:1367-72.
16. Cozzone AJ. Bacterial tyrosine kinases: novel targets for antibacterial therapy? Trends Microbiol 2009;17:536-43.
17. de Keijzer J, de Haas PE, de Ru AH et al. Disclosure of selective advantages in the "modern" sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics. Mol Cell Proteomics 2014;13:2632-45.
18. Devos S, Van Oudenhove L, Stremersch S et al. The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front Microbiol 2015;6:298.
19. Dwyer DJ, Collins JJ, Walker GC. Unraveling the physiological complexities of antibiotic lethality. Annu Rev Pharmacol 2015;55:313-32.
20. Editorial. Method of the Year 2012. Nat Methods 2013;10:1-1.
21. Egli T. Microbial growth and physiology: a call for better craftsmanship. Front Microbiol 2015;6:287.
22. Feng J, Billal DS, Lupien A et al. Proteomic and transcriptomic analysis of linezolid resistance in Streptococcus pneumoniae. J Proteome Res 2011;10:4439-52.
23. Fischer A, Yang S-J, BayerAS et al. Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach. J Antimicrob Chemoth 2011;66:1696-711.
24. Gonçalves A, Poeta P, Monteiro R et al. Comparative proteomics of an extended spectrum β-lactamase producing Escherichia coli strain from the Iberian wolf. J Proteomics 2014;104:80-93.
25. Gupta N, Tanner S, Jaitly N et al. Whole proteome analysis of post-translational modifications: applications of massspectrometry for proteogenomic annotation. Genome Res 2007;17:1362-77.
26. Herbst F-A, Søndergaard MT, Kjeldal H et al. Major proteomic changes associated with amyloid-induced biofilm formation in Pseudomonas aeruginosa PAO1. J Proteome Res 2015;14:72-81.
27. Hubbard T, Barker D, Birney E et al. The ensembl genome database project. Nucleic Acids Res 2002;30:38-41.
28. Kalume DE,Molina H, Pandey A. Tackling the phosphoproteome:tools and strategies. Curr Opin Chem Biol 2003;7:64-9.
29. Koul A, Vranckx L, Dhar N et al. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodellingof bacterial metabolism. Nat Commun 2014;5:1-10.
30. Krüger R, Kübler D, Pallissé R et al. Protein and proteome phosphorylation stoichiometry analysis by element mass spectrometry. Anal Chem 2006;78:1987-94.
31. Lambert PA. Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliver Rev 2005;57:1471-85.
32. Leblanc C, Prudhomme T, Tabouret G et al. 4_-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo. PLoS Pathog 2012;8:e1003097.
33. Lee SY, Yun SH, Lee YG et al. Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202. J Antimicrob Chemoth 2014;69:1483-91.
34. Lew JM, Kapopoulou A, Jones LM et al. Tuberculosis. Tuberculosis 2011;91:1-7.
35. Li H, Zhang DF, Lin XM et al. Outer membrane proteomics of kanamycin-resistant Escherichia coli identified MipA as a novel antibiotic resistance-related protein. FEMS Microbiol Lett 2015;362:74.
36. Li Z, Wang Y, Yao Q et al. Diverse and divergent protein posttranslational modifications in two growth stages of a natural microbial community. Nat Commun 2014;5:1-11.
37. Lin X, Kang L, Li H et al. Fluctuation of multiple metabolic pathways is required for Escherichia coli in response to chlortetracycline stress. Mol BioSyst 2014a;10:901.
38. Lin X-M, Yang J-N, Peng X-X et al. A novel negative regulation mechanism of bacterial outer membrane proteins in response to antibiotic resistance. J Proteome Res 2010;9:5952-59.
39. Lin X-M, Yang M-J, Li H et al. Decreased expression of LamB and Odp1 complex is crucial for antibiotic resistance in Escherichia coli. J Proteomics 2014b;98:244-53.
40. Liu W, Zou D, Wang X et al. Proteomic analysis of clinical isolate of Stenotrophomonas maltophilia with blaNDM-1, blaL1 and blaL2β-Lactamase genes under imipenem treatment. J Proteome Res 2012;11:4024-33.
41. Liu X, Hu Y, Pai P-J et al. Label-free quantitative proteomics analysis of antibiotic response in Staphylococcus aureus to oxacillin. J Proteome Res 2014;13:1223-33.
42. McArthur AG, Wright GD. Bioinformatics of antimicrobial resistance in the age of molecular epidemiology. Curr Opin Microbiol 2015;27:45-50.
43. Manai M, Cozzone AJ. Analysis of the protein-kinase activity of Escherichia coli cells. Biochem Bioph Res Co 1979;91:819-26.
44. Martinez JL, Rojo F. Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev 2011;35:768-89.
45. Mijakovic I, Macek B. Impact of phosphoproteomics on studies of bacterial physiology. FEMS Microbiol Rev 2012;36:877-92.
46. Nabu S, Lawung R, Isarankura-Na-Ayudhya P et al. Reference map and comparative proteomic analysis of Neisseria gonorrhoeae displaying high resistance against spectinomycin. J Med Microbiol 2014;63:371-85.
47. O'Neill J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. The Review on Antimicrobial Resistance, 2014, http://amr-review.org (14 September 2015, date last accessed).
48. Park AJ, Murphy K, Krieger JR et al. A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry. Mol Cell Proteomics 2014;13:1095-105.
49. Park AJ, Murphy K, Surette MD et al. Tracking the dynamic relationship between cellular systems and extracellular subproteomes in Pseudomonas aeruginosa biofilms. J Proteome Res 2015;4:4524-37.
50. Park AJ, Surette MD, Khursigara CM. Antimicrobial targets localize to the extracellular vesicle-associated proteome of Pseudomonas aeruginosa grown in a biofilm. Front Microbiol 2014;5:464.
51. Peterson AC, Russell JD, Bailey DJ et al. Parallel reaction monitoring for high resolution mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics 2012;11:1475-88.
52. Piras C, Soggiu A, VivianaGet al. Mechanisms of antibiotic resistance to enrofloxacin in uropathogenic Escherichia coli in dog. J Proteomics 2015;127:365-76.
53. Post D, Held JM, Ketterer MR et al. Comparative analyses of proteins from Haemophilus influenzae biofilm and planktonic populations using metabolic labeling and mass spectrometry. BMC Microbiol 2014;14:2322.
54. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Global Health 2015, 2047773215Y.000-10.
55. Rabilloud T, Lelong C. Two-dimensional gel electrophoresis in proteomics: a tutorial. J Proteomics 2011;74:1829-41.
56. Ramos S, Chafsey I, Silva N et al. Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain. J Proteomics 2015;113:378-87.
57. Rastogi N, Labrousse VXR, Goh KS. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 1996;33:167-75.
58. Sheridan A, Lenahan M, Condell O et al. Proteomic and phenotypic analysis of triclosan tolerant verocytotoxigenic Escherichia coli O157:H19. J Proteomics 2013;80:78-90.
59. Smith RA, M'ikanatha NM, Read AF. Antibiotic resistance:a primer and call to action. Health Commun 2015;30:309-14.
60. Soares NC, Spät P, Méndez JA et al. Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii:comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. J Proteomics 2014;102:113-24.
61. Solis N, Parker BL, Kwong SM et al. Staphylococcus aureus surface proteins involved in adaptation to oxacillin identified using a novel cell shaving approach. J Proteome Res 2014;13:2954-72.
62. Tatusova T, Ciufo S, Fedorov B et al. RefSeq microbial genomes database: new representation and annotation strategy. Nucleic Acids Res 2013;42:D553-9.
63. Tiwari V, Vashistt J, Kapil A et al. Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS One 2012;7:e39451.
64. Truong-Bolduc QC, Ding Y, Hooper DC. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus. J Bacteriol 2008;190:7375-81.
65. Wang JY, Koshland DE. Evidence for protein kinase activities in the prokaryote Salmonella typhimurium. J Biol Chem 1978;253:7605-8.
66. Wang X, He X, Jiang Z et al. Proteomic analysis of the Enterococcus faecalis V583 strain and clinical isolate V309 under vancomycin treatment. J Proteome Res 2010;9:1772-85.
67. Whiteside MD, Winsor GL, Laird MR et al. OrtholugeDB: a bacterial and archaeal orthology resource for improved comparative genomic analysis. Nucleic Acids Res 2013;41:D366-76.
68. Wei Q, Tarigghi S, Dotsch A et al. Phenotypic and genomewide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa. PLoS One 2011;6:e29276.
69. Winsor GL, Lam DKW, Fleming L et al. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 2010;39:D596-600.
70. Wishart DS, Knox C, Guo AC et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2007;36:D901-6.
71. Wu X, Held K, Zheng C et al. Dynamic proteome response of Pseudomonas aeruginosa to tobramycin antibiotic treatment. Mol Cell Proteomics 2015;14:2126-37.
72. Xie L,Wang X, Zeng J et al. Proteome-wide lysine acetylation profiling of the human pathogen Mycobacterium tuberculosis. Int J Biochem Cell B 2015;59:193-202.
73. Yang X-Y, Zhang L, Liu J et al. Proteomic analysis on the antibacterial activity of a Ru(II) complex against Streptococcus pneumoniae. J Proteomics 2015;115:107-16.
74. Yun SH, Choi C-W, Kwon S-O et al. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res 2011;10:459-69.
75. Zielke RA,Wierzbicki IH,Weber JV et al. Quantitative proteomics of the Neisseria gonorrhoeae cell envelope and membrane vesicles for the discovery of potential therapeutic targets. Mol Cell Proteomics 2014;13:1299-317.